Showing results (251-260 of 408) with videos related to

Sort By:
Pageof 41
Infection Control and Hospital Epidemiology|January 31, 2022
Improving antibiotic use for sinusitis and upper respiratory tract infections: A virtual-visit antibiotic stewardship initiativeAnastasia I Wasylyshyn, Keith S Kaye, Julia Chen, et al.
Journal of the American Geriatrics Society|December 5, 2008
The effect of surgical site infection on older operative patientsKeith S Kaye, Deverick J Anderson, Richard Sloane, et al.
Infection Control and Hospital Epidemiology|June 16, 2015
Building and Validating a Computerized Algorithm for Surveillance of Ventilator-Associated EventsTal Mann, Joseph Ellsworth, Najia Huda, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 17, 2005
Physicians' acceptable treatment failure rates in antibiotic therapy for coagulase-negative staphylococcal catheter-associated bacteremia: implications for reducing treatment durationEli N Perencevich, Anthony D Harris, Keith S Kaye, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 6, 2026
The Impact of Colistin MIC on Clinical Failure and Mortality: Insights from the OVERCOME TrialJason M Pogue, Michael J Rybak, Jacinda C Abdul-Mutakabbir, et al.
Antimicrobial Agents and Chemotherapy|October 17, 2012
Epidemiology of vancomycin-resistant Enterococcus faecalis: a case-case-control studyKayoko Hayakawa, Dror Marchaim, Mohan Palla, et al.
Medrxiv : the Preprint Server for Health Sciences|March 31, 2025
The association between undetected heteroresistance and antibiotic treatment failure in complicated urinary tract infectionCarter N Abbott, Aditi Dhillon, Sushma Timalsina, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 19, 2025
The Impact of Synergistic Therapy Between Colistin and Meropenem on Outcomes of Patients With Pneumonia or Bloodstream Infection Due to Carbapenem-Resistant Gram-Negative PathogensMariya Huralska, Jason M Pogue, Michael Rybak, et al.
Antimicrobial Agents and Chemotherapy|June 14, 2021
In Vitro Antibacterial Activity of Cefiderocol against Multidrug-Resistant Acinetobacter baumanniiJacinda C Abdul-Mutakabbir, Logan Nguyen, Philip T Maassen, et al.
Pageof 41